Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Hemanext Inc. currently manages 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 6 distinct examiners, meaning that each pending action is assigned to a different individual. These matters are spread across 4 distinct art units, which suggests the portfolio covers multiple specific technical niches within the broader biotechnology sector.
PENNINGTON, KATIE LEIGH is identified as the busiest examiner for this portfolio, though she currently holds only 1 pending office action. This distribution of work means that prosecution strategies must be tailored to the individual preferences of the various examiners. The presence of the 4 distinct art units implies that the pending office actions involve diverse subject matter requiring different examination standards.
Because no single examiner, including PENNINGTON, KATIE LEIGH, handles more than 1 pending action, the company faces a prosecution landscape where each case is independent. Practitioners should prepare for varied feedback, as the lack of examiner overlap prevents the reuse of specific examiner-specific arguments across the active portfolio.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PENNINGTON, KATIE LEIGH | 1 | 29.7% | +60.0% |
| SPENCER, ANDREA LYNNE MORRIS | 1 | 22.2% | +35.7% |
| BARRON, SEAN C | 1 | 52.9% | +30.9% |
| FOX, ALLISON M | 1 | 71.2% | +35.7% |
| ZHU, JIANJIAN | 1 | 58.8% | +82.4% |
| MIANO, JOSEPH PAUL | 1 | 36.0% | +63.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17241648 | Methods for the Storage of Whole Blood, and Compositions Thereof | MIANO, JOSEPH PAUL | 107d overdue |
| 17954138 | Methods for the Storage of Whole Blood, and Compositions Thereof | SPENCER, ANDREA LYNNE MORRIS | 25d overdue |
| 18549520 | Methods for Storing Hematopoietic Stem Cells | PENNINGTON, KATIE LEIGH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17241648 | Methods for the Storage of Whole Blood, and Compositions Thereof | MIANO, JOSEPH PAUL | 107d overdue |
| 17954138 | Methods for the Storage of Whole Blood, and Compositions Thereof | SPENCER, ANDREA LYNNE MORRIS | 25d overdue |
| 17639823 | Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide | FOX, ALLISON M | 8d overdue |
| 17772947 | Anaerobic Blood Storage and Pathogen Inactivation Method | BARRON, SEAN C | 29d |
| 18549520 | Methods for Storing Hematopoietic Stem Cells | PENNINGTON, KATIE LEIGH | — |
| 17292355 | METHODS FOR THE PRESERVATION OF REAGENT RED BLOOD CELLS USING CARBON MONOXIDE | ZHU, JIANJIAN | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1634 | 1 |
| 1653 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18549520 | Methods for Storing Hematopoietic Stem Cells | PENNINGTON, KATIE LEIGH | 1634 | §103§112 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 17954138 | Methods for the Storage of Whole Blood, and Compositions Thereof | SPENCER, ANDREA LYNNE MORRIS | 1631 | §102§103§112 | Final Rejection | 25d overdue | Pending | Sep 27, 2022 |
| 17772947 | Anaerobic Blood Storage and Pathogen Inactivation Method | BARRON, SEAN C | 1653 | §103Other | Final Rejection | 29d | Pending | Apr 28, 2022 |
| 17639823 | Methods for the Preservation of Reagent Red Blood Cells Using Carbon Monoxide | FOX, ALLISON M | 1633 | §103 | Final Rejection | 8d overdue | Pending | Mar 02, 2022 |
| 17292355 | METHODS FOR THE PRESERVATION OF REAGENT RED BLOOD CELLS USING CARBON MONOXIDE | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | — | Pending | May 07, 2021 |
| 17241648 | Methods for the Storage of Whole Blood, and Compositions Thereof | MIANO, JOSEPH PAUL | 1631 | §102§103Other | Final Rejection | 107d overdue | Pending | Apr 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial